UnitedHealth Group Inc
NYSE:UNH
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
237.77
599.47
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
UNH
stock under the Base Case scenario is
460.57
USD.
Compared to the current market price of 333.49 USD,
UnitedHealth Group Inc
is
Undervalued by 28%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for UnitedHealth Group Inc.
| US |
A
|
Anthem Inc
LSE:0HG8
|
|
| US |
|
Elevance Health Inc
NYSE:ELV
|
|
| US |
|
Humana Inc
NYSE:HUM
|
|
| US |
|
Centene Corp
NYSE:CNC
|
|
| US |
|
Healthequity Inc
NASDAQ:HQY
|
|
| US |
|
Molina Healthcare Inc
NYSE:MOH
|
|
| US |
M
|
Magellan Health Inc
F:MAH1
|
|
| US |
|
Progyny Inc
NASDAQ:PGNY
|
|
| BR |
|
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
|
|
| US |
|
Clover Health Investments Corp
NASDAQ:CLOV
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
With UnitedHealthcare’s growing reliance on Medicare Advantage enrollment, any regulatory caps or stricter oversight on Medicare reimbursement rates could significantly compress margins and stall enrollment growth in this highly profitable segment.
If rising costs in specialty drugs and advanced therapies outpace the company’s ability to adjust plan premiums, UnitedHealth Group could face margin erosion, particularly across employer-sponsored and individual health plans.
Ongoing governmental and public scrutiny over vertical integration, especially the interplay between Optum’s pharmacy benefit management and UnitedHealthcare’s insurance offerings, raises the risk of antitrust action or additional compliance costs cutting into profitability.
UnitedHealth Group’s integrated business model, combining UnitedHealthcare’s insurance network with Optum’s technology, pharmacy benefit management, and care delivery services, positions the company to capitalize on cost efficiencies and maintain industry-leading profit margins.
Rapid expansion into value-based care models, such as OptumCare clinics, allows UnitedHealth to manage patient outcomes and costs more effectively, fostering deeper relationships with both providers and payers.
The company’s consistent generation of substantial free cash flow provides ample flexibility to pursue strategic acquisitions, bolster dividend payments, and invest in data analytics capabilities to drive further growth.
Balance Sheet Decomposition
UnitedHealth Group Inc
| Cash & Short-Term Investments | 27.2B |
| Insurance Receivable | 22.7B |
| PP&E | 11.1B |
| Long-Term Investments | 56.4B |
| Other Assets | 197.9B |
| Insurance Policy Liabilities | 43.5B |
| Long Term Debt | 72.4B |
| Other Liabilities | 103.5B |
Wall St
Price Targets
UNH Price Targets Summary
UnitedHealth Group Inc
According to Wall Street analysts, the average 1-year price target for
UNH
is 397.41 USD
with a low forecast of 199.98 USD and a high forecast of 462 USD.
Dividends
Current shareholder yield for
UNH is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
UNH
stock under the Base Case scenario is
460.57
USD.
Compared to the current market price of 333.49 USD,
UnitedHealth Group Inc
is
Undervalued by 28%.